Class Action Claims Celgene Gamed The System to Guard Thalomid, Revlimid

Generic Line
A A
A health plan for a carpenters’ union filed a class action lawsuit against Celgene, claiming the drugmaker engaged in anti-competitive practices to maintain its monopoly on Thalomid (thalidomide) and Revlimid (lenalidomide).

To View This Article:

Login

Subscribe To Generic Line